intensive medical therapy
OtherDual antiplatelet therapy, high potency statins, HTN control, lifestyle modification
NCT Number: NCT05300737
The purpose of this study is to build upon trials done over 30 years ago, which did not include statins, new antiplatelet agents, and newer antihypertensive medications. Since the landmark trials (NASCET, ECST), there have been new developments in medical stroke prevention, which creates a gap in knowledge. The aim of this study is to evaluate that clinical care with Intensive Medical Therapy (IMT) alone, the one year stroke rate in patients with symptomatic carotid stenosis and low risk clinical features will be <5%.
This study is active but is not currently recruiting participants.
40 year and older
All sexes
Observational
Calgary Health Sciences Center, Calgary, Alberta, Canada
This study will only be evaluating clinical care and no interventions will be done specifically for this research.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
In addition, patients must have at least one clinical or radiologic marker of reduced stroke risk
Clinical Reduced Stroke RISK:
Radiologic Reduced Stroke RISK:
Exclusion criteria
Atrial fibrillation or other high-risk sources of cardiac embolism unless it is device detected AF only or duration <6 minutes
Alcohol and substance abuse within the prior 24 months
Clinically significant bleeding diathesis (platelet count <100K, prothrombin time >14 seconds)
Clear indication for therapeutic anticoagulation (for example, DVT or pulmonary embolism within past 3 months)
Left ventricular ejection fraction <20%
Known allergy or intolerance to aspirin or clopidogrel
Life expectancy less than 12 months
Moderate/severe dementia (Mini-mental or MOCA score <22
Modified Rankin score of >4
Nonatherosclerotic cause of carotid stenosis
Most recent symptomatic event >180 days from the time of enrollment
-
Dual antiplatelet therapy, high potency statins, HTN control, lifestyle modification
Time frame: within 12 months
ipsilateral to carotid stenosis, with radiologic confirmation
Time frame: within 12 months
ECG will be performed for suspected myocardial infarction and will be diagnosed if appropriate ST changes and confirmation with troponin measurements
University of Maryland, Baltimore
Other
Symptomatic Carotid Outcomes Registry With Multi-center Evaluation
Acronym: SCORE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00190398
Arterial Occlusive Diseases, Arteriosclerosis
Paris, Île-de-France Region, France
View Trial DetailsNCT05416853
Arterial Occlusive Diseases, Brain Diseases
Hefei, Anhui, China
View Trial DetailsNCT06947720
Arterial Occlusive Diseases, Brain Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT02476396
Arterial Occlusive Diseases, Brain Diseases
Madison, Wisconsin, United States
View Trial Details